Search

everythinglearnresearchcommunity

for

Search:↓

High levels of the seizure medication sodium valproate can cause hair loss.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

The rapid corticotropin test is a quick and simple way to diagnose adrenal insufficiency.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Treat pattern hair loss with finasteride and topical minoxidil.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

SLE patients experience two patterns of non-inflammatory symptoms: intermittent and persistent.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Many adults in Porto have acne, but few know or treat it.

Young women with PCOS without additional risk factors may have normal heart function.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.